Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05995353
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Large-scale testing (Phase 3)Study completedNCT01086553
What this trial is testing

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Who this might be right for
Crohn´s Disease
Dr. Falk Pharma GmbH 471
Testing effectiveness (Phase 2)Looking for participantsNCT07186101
What this trial is testing

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 252
Large-scale testing (Phase 3)Study completedNCT01277666
What this trial is testing

Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 608
Not applicableUnknownNCT05099653
What this trial is testing

Study of the Impact of a Physical Activity Programme on the Quality of Life of Patients With Inflammatory Bowel Disease

Who this might be right for
Crohn Disease Haemorrhagic Rectocolitis
Raincy Montfermeil Hospital Group 30
Not applicableStudy completedNCT04589338
What this trial is testing

Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesExercise Therapy
University of Liege 24
Large-scale testing (Phase 3)Ended earlyNCT01805791
What this trial is testing

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 201
Testing effectiveness (Phase 2)Looking for participantsNCT07118059
What this trial is testing

Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial

Who this might be right for
TuberculosisInflammation BiomarkersLiver Function Tests+4 more
North-West University, South Africa 40
Large-scale testing (Phase 3)Study completedNCT03945188
What this trial is testing

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 433
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Not applicableStudy completedNCT01323283
What this trial is testing

Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children

Who this might be right for
Lifestyle-related ConditionOverweight and ObesityEssential Fatty Acid Deficiency
Karolinska Institutet 423
Large-scale testing (Phase 3)Study completedNCT04156620
What this trial is testing

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Who this might be right for
Ankylosing Spondylitis
Novartis Pharmaceuticals 527
Large-scale testing (Phase 3)Study completedNCT00032799
What this trial is testing

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 905
Not applicableLooking for participantsNCT07152431
What this trial is testing

Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease

Who this might be right for
Crohn Disease
University of Edinburgh 30
Not applicableActive Not RecruitingNCT05841537
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,019
Large-scale testing (Phase 3)Study completedNCT04724629
What this trial is testing

Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)

Who this might be right for
Covid19
University of Sao Paulo 60
Very early researchStudy completedNCT00783042
What this trial is testing

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Who this might be right for
AtherosclerosisInflammatory Activity in Coronary Arteries
AstraZeneca 80
Testing effectiveness (Phase 2)Looking for participantsNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Post-approval studies (Phase 4)Study completedNCT02318667
What this trial is testing

Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 38
Not applicableUnknownNCT02193802
What this trial is testing

Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 42
Next Page